Pharmacological property, mechanism of action and clinical study results of Pabinafusp Alfa (Genetical Recombination) (IZCARGO® I.V. Infusion 10 mg) as the therapeutic for Mucopolysaccharidosis type-II (Hunter syndrome)
2017 ◽
Vol 120
(1-2)
◽
pp. S107-S108
2011 ◽
Vol 155
(6)
◽
pp. 1329-1335
◽
2020 ◽
Vol 24
◽
pp. 100630
2020 ◽
pp. 71-117
2016 ◽
Vol 118
(3)
◽
pp. 190-197
◽